nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Ethinyl Estradiol—osteoporosis	0.217	0.421	CbGbCtD
Fidaxomicin—ABCB1—Conjugated Estrogens—osteoporosis	0.159	0.309	CbGbCtD
Fidaxomicin—ABCB1—Estradiol—osteoporosis	0.14	0.271	CbGbCtD
Fidaxomicin—Pruritus—Calcium Acetate—osteoporosis	0.0027	0.0056	CcSEcCtD
Fidaxomicin—Neutropenia—Pamidronate—osteoporosis	0.00268	0.00555	CcSEcCtD
Fidaxomicin—Malnutrition—Estropipate—osteoporosis	0.00266	0.0055	CcSEcCtD
Fidaxomicin—Immune system disorder—Ibandronate—osteoporosis	0.00265	0.00548	CcSEcCtD
Fidaxomicin—Abdominal distension—Zoledronate—osteoporosis	0.00264	0.00546	CcSEcCtD
Fidaxomicin—Flatulence—Estropipate—osteoporosis	0.00262	0.00542	CcSEcCtD
Fidaxomicin—Dysphagia—Zoledronate—osteoporosis	0.00262	0.00542	CcSEcCtD
Fidaxomicin—Flatulence—Alendronate—osteoporosis	0.00258	0.00534	CcSEcCtD
Fidaxomicin—Dysgeusia—Alendronate—osteoporosis	0.00257	0.00531	CcSEcCtD
Fidaxomicin—Malnutrition—Ibandronate—osteoporosis	0.00255	0.00528	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Risedronate—osteoporosis	0.00254	0.00526	CcSEcCtD
Fidaxomicin—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00254	0.00525	CcSEcCtD
Fidaxomicin—Flatulence—Raloxifene—osteoporosis	0.00254	0.00525	CcSEcCtD
Fidaxomicin—Dizziness—Calcium Acetate—osteoporosis	0.00253	0.00523	CcSEcCtD
Fidaxomicin—Dysphagia—Conjugated Estrogens—osteoporosis	0.00252	0.00522	CcSEcCtD
Fidaxomicin—Flatulence—Ibandronate—osteoporosis	0.00251	0.0052	CcSEcCtD
Fidaxomicin—Dysgeusia—Ibandronate—osteoporosis	0.0025	0.00517	CcSEcCtD
Fidaxomicin—Neutropenia—Zoledronate—osteoporosis	0.00245	0.00507	CcSEcCtD
Fidaxomicin—Dysgeusia—Calcitriol—osteoporosis	0.00244	0.00506	CcSEcCtD
Fidaxomicin—Angioedema—Estropipate—osteoporosis	0.00243	0.00503	CcSEcCtD
Fidaxomicin—Vomiting—Calcium Acetate—osteoporosis	0.00243	0.00503	CcSEcCtD
Fidaxomicin—Anaemia—Alendronate—osteoporosis	0.00242	0.00501	CcSEcCtD
Fidaxomicin—Angioedema—Alendronate—osteoporosis	0.00239	0.00495	CcSEcCtD
Fidaxomicin—Anaemia—Ibandronate—osteoporosis	0.00236	0.00488	CcSEcCtD
Fidaxomicin—Angioedema—Ibandronate—osteoporosis	0.00233	0.00482	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.00228	0.00471	CcSEcCtD
Fidaxomicin—Nausea—Calcium Acetate—osteoporosis	0.00227	0.0047	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00225	0.00465	CcSEcCtD
Fidaxomicin—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00224	0.00463	CcSEcCtD
Fidaxomicin—Dyspepsia—Etidronic acid—osteoporosis	0.00221	0.00457	CcSEcCtD
Fidaxomicin—Immune system disorder—Risedronate—osteoporosis	0.00218	0.00451	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00218	0.00451	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00216	0.00446	CcSEcCtD
Fidaxomicin—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00216	0.00446	CcSEcCtD
Fidaxomicin—Constipation—Etidronic acid—osteoporosis	0.00215	0.00444	CcSEcCtD
Fidaxomicin—Nervous system disorder—Estropipate—osteoporosis	0.00213	0.00441	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.00213	0.0044	CcSEcCtD
Fidaxomicin—Dry mouth—Ibandronate—osteoporosis	0.00212	0.00439	CcSEcCtD
Fidaxomicin—Skin disorder—Estropipate—osteoporosis	0.00211	0.00436	CcSEcCtD
Fidaxomicin—Malnutrition—Risedronate—osteoporosis	0.0021	0.00435	CcSEcCtD
Fidaxomicin—Dry mouth—Calcitriol—osteoporosis	0.00208	0.0043	CcSEcCtD
Fidaxomicin—Immune system disorder—Pamidronate—osteoporosis	0.00207	0.00429	CcSEcCtD
Fidaxomicin—Flatulence—Risedronate—osteoporosis	0.00207	0.00429	CcSEcCtD
Fidaxomicin—Nervous system disorder—Raloxifene—osteoporosis	0.00206	0.00427	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Estradiol—osteoporosis	0.00206	0.00426	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00205	0.00425	CcSEcCtD
Fidaxomicin—Skin disorder—Raloxifene—osteoporosis	0.00204	0.00423	CcSEcCtD
Fidaxomicin—Nervous system disorder—Ibandronate—osteoporosis	0.00204	0.00422	CcSEcCtD
Fidaxomicin—Abdominal distension—Estradiol—osteoporosis	0.00203	0.00421	CcSEcCtD
Fidaxomicin—Skin disorder—Ibandronate—osteoporosis	0.00202	0.00418	CcSEcCtD
Fidaxomicin—Dysphagia—Estradiol—osteoporosis	0.00202	0.00418	CcSEcCtD
Fidaxomicin—Nausea—Ergocalciferol—osteoporosis	0.00201	0.00415	CcSEcCtD
Fidaxomicin—Malnutrition—Pamidronate—osteoporosis	0.002	0.00413	CcSEcCtD
Fidaxomicin—Abdominal pain—Etidronic acid—osteoporosis	0.00198	0.0041	CcSEcCtD
Fidaxomicin—Skin disorder—Calcitriol—osteoporosis	0.00198	0.0041	CcSEcCtD
Fidaxomicin—Angioedema—Ethinyl Estradiol—osteoporosis	0.00197	0.00408	CcSEcCtD
Fidaxomicin—Dysgeusia—Pamidronate—osteoporosis	0.00196	0.00405	CcSEcCtD
Fidaxomicin—Anaemia—Risedronate—osteoporosis	0.00194	0.00402	CcSEcCtD
Fidaxomicin—Angioedema—Risedronate—osteoporosis	0.00192	0.00397	CcSEcCtD
Fidaxomicin—Dyspepsia—Estropipate—osteoporosis	0.00191	0.00395	CcSEcCtD
Fidaxomicin—Immune system disorder—Zoledronate—osteoporosis	0.00189	0.00392	CcSEcCtD
Fidaxomicin—Dyspepsia—Alendronate—osteoporosis	0.00188	0.00389	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Estropipate—osteoporosis	0.00187	0.00388	CcSEcCtD
Fidaxomicin—Constipation—Estropipate—osteoporosis	0.00186	0.00384	CcSEcCtD
Fidaxomicin—Dyspepsia—Raloxifene—osteoporosis	0.00185	0.00383	CcSEcCtD
Fidaxomicin—Hypersensitivity—Etidronic acid—osteoporosis	0.00185	0.00383	CcSEcCtD
Fidaxomicin—Anaemia—Pamidronate—osteoporosis	0.00185	0.00382	CcSEcCtD
Fidaxomicin—Dyspepsia—Ibandronate—osteoporosis	0.00183	0.00379	CcSEcCtD
Fidaxomicin—Constipation—Alendronate—osteoporosis	0.00183	0.00378	CcSEcCtD
Fidaxomicin—Angioedema—Pamidronate—osteoporosis	0.00183	0.00378	CcSEcCtD
Fidaxomicin—Malnutrition—Zoledronate—osteoporosis	0.00183	0.00378	CcSEcCtD
Fidaxomicin—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00182	0.00377	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00182	0.00377	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Estradiol—osteoporosis	0.00182	0.00377	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00182	0.00376	CcSEcCtD
Fidaxomicin—Decreased appetite—Ibandronate—osteoporosis	0.00181	0.00374	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.0018	0.00372	CcSEcCtD
Fidaxomicin—Dysgeusia—Zoledronate—osteoporosis	0.00179	0.0037	CcSEcCtD
Fidaxomicin—Constipation—Ibandronate—osteoporosis	0.00178	0.00368	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00178	0.00368	CcSEcCtD
Fidaxomicin—Pruritus—Etidronic acid—osteoporosis	0.00178	0.00367	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Estropipate—osteoporosis	0.00178	0.00367	CcSEcCtD
Fidaxomicin—Decreased appetite—Calcitriol—osteoporosis	0.00177	0.00367	CcSEcCtD
Fidaxomicin—Malnutrition—Conjugated Estrogens—osteoporosis	0.00176	0.00364	CcSEcCtD
Fidaxomicin—Dry mouth—Risedronate—osteoporosis	0.00175	0.00362	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Alendronate—osteoporosis	0.00175	0.00362	CcSEcCtD
Fidaxomicin—Constipation—Calcitriol—osteoporosis	0.00174	0.00361	CcSEcCtD
Fidaxomicin—Flatulence—Conjugated Estrogens—osteoporosis	0.00173	0.00358	CcSEcCtD
Fidaxomicin—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00173	0.00357	CcSEcCtD
Fidaxomicin—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00172	0.00356	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Raloxifene—osteoporosis	0.00172	0.00356	CcSEcCtD
Fidaxomicin—Abdominal pain—Estropipate—osteoporosis	0.00172	0.00355	CcSEcCtD
Fidaxomicin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00171	0.00354	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Estradiol—osteoporosis	0.0017	0.00352	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Ibandronate—osteoporosis	0.0017	0.00352	CcSEcCtD
Fidaxomicin—Abdominal pain—Alendronate—osteoporosis	0.00169	0.0035	CcSEcCtD
Fidaxomicin—Anaemia—Zoledronate—osteoporosis	0.00169	0.00349	CcSEcCtD
Fidaxomicin—Nervous system disorder—Risedronate—osteoporosis	0.00168	0.00348	CcSEcCtD
Fidaxomicin—Angioedema—Zoledronate—osteoporosis	0.00167	0.00345	CcSEcCtD
Fidaxomicin—Skin disorder—Risedronate—osteoporosis	0.00167	0.00345	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Calcitriol—osteoporosis	0.00167	0.00345	CcSEcCtD
Fidaxomicin—Abdominal pain—Raloxifene—osteoporosis	0.00166	0.00344	CcSEcCtD
Fidaxomicin—Abdominal pain—Ibandronate—osteoporosis	0.00165	0.00341	CcSEcCtD
Fidaxomicin—Abdominal pain—Calcitriol—osteoporosis	0.00161	0.00333	CcSEcCtD
Fidaxomicin—Angioedema—Conjugated Estrogens—osteoporosis	0.00161	0.00332	CcSEcCtD
Fidaxomicin—Hypersensitivity—Estropipate—osteoporosis	0.0016	0.00331	CcSEcCtD
Fidaxomicin—Nervous system disorder—Pamidronate—osteoporosis	0.0016	0.00331	CcSEcCtD
Fidaxomicin—Vomiting—Etidronic acid—osteoporosis	0.0016	0.0033	CcSEcCtD
Fidaxomicin—Rash—Etidronic acid—osteoporosis	0.00158	0.00327	CcSEcCtD
Fidaxomicin—Dermatitis—Etidronic acid—osteoporosis	0.00158	0.00327	CcSEcCtD
Fidaxomicin—Hypersensitivity—Alendronate—osteoporosis	0.00158	0.00326	CcSEcCtD
Fidaxomicin—Headache—Etidronic acid—osteoporosis	0.00157	0.00325	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00154	0.00319	CcSEcCtD
Fidaxomicin—Pruritus—Estropipate—osteoporosis	0.00154	0.00318	CcSEcCtD
Fidaxomicin—Hypersensitivity—Ibandronate—osteoporosis	0.00153	0.00317	CcSEcCtD
Fidaxomicin—Dyspnoea—Risedronate—osteoporosis	0.00153	0.00316	CcSEcCtD
Fidaxomicin—Dry mouth—Zoledronate—osteoporosis	0.00152	0.00314	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00152	0.00314	CcSEcCtD
Fidaxomicin—Pruritus—Alendronate—osteoporosis	0.00151	0.00313	CcSEcCtD
Fidaxomicin—Dyspepsia—Risedronate—osteoporosis	0.00151	0.00312	CcSEcCtD
Fidaxomicin—Constipation—Ethinyl Estradiol—osteoporosis	0.0015	0.00311	CcSEcCtD
Fidaxomicin—Hypersensitivity—Calcitriol—osteoporosis	0.0015	0.00311	CcSEcCtD
Fidaxomicin—Nausea—Etidronic acid—osteoporosis	0.00149	0.00308	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00149	0.00307	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Risedronate—osteoporosis	0.00148	0.00306	CcSEcCtD
Fidaxomicin—Pruritus—Ibandronate—osteoporosis	0.00147	0.00305	CcSEcCtD
Fidaxomicin—Constipation—Risedronate—osteoporosis	0.00147	0.00304	CcSEcCtD
Fidaxomicin—Nervous system disorder—Zoledronate—osteoporosis	0.00146	0.00302	CcSEcCtD
Fidaxomicin—Immune system disorder—Estradiol—osteoporosis	0.00146	0.00302	CcSEcCtD
Fidaxomicin—Dyspnoea—Pamidronate—osteoporosis	0.00145	0.00301	CcSEcCtD
Fidaxomicin—Skin disorder—Zoledronate—osteoporosis	0.00145	0.00299	CcSEcCtD
Fidaxomicin—Pruritus—Calcitriol—osteoporosis	0.00144	0.00298	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00144	0.00298	CcSEcCtD
Fidaxomicin—Dyspepsia—Pamidronate—osteoporosis	0.00144	0.00297	CcSEcCtD
Fidaxomicin—Dizziness—Estropipate—osteoporosis	0.00144	0.00297	CcSEcCtD
Fidaxomicin—Decreased appetite—Pamidronate—osteoporosis	0.00142	0.00293	CcSEcCtD
Fidaxomicin—Dizziness—Alendronate—osteoporosis	0.00141	0.00293	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00141	0.00291	CcSEcCtD
Fidaxomicin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00141	0.00291	CcSEcCtD
Fidaxomicin—Malnutrition—Estradiol—osteoporosis	0.00141	0.00291	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Risedronate—osteoporosis	0.0014	0.0029	CcSEcCtD
Fidaxomicin—Constipation—Pamidronate—osteoporosis	0.00139	0.00289	CcSEcCtD
Fidaxomicin—Skin disorder—Conjugated Estrogens—osteoporosis	0.00139	0.00288	CcSEcCtD
Fidaxomicin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00139	0.00288	CcSEcCtD
Fidaxomicin—Dizziness—Raloxifene—osteoporosis	0.00139	0.00288	CcSEcCtD
Fidaxomicin—Flatulence—Estradiol—osteoporosis	0.00139	0.00287	CcSEcCtD
Fidaxomicin—Vomiting—Estropipate—osteoporosis	0.00138	0.00286	CcSEcCtD
Fidaxomicin—Dysgeusia—Estradiol—osteoporosis	0.00138	0.00285	CcSEcCtD
Fidaxomicin—Dizziness—Ibandronate—osteoporosis	0.00138	0.00285	CcSEcCtD
Fidaxomicin—Rash—Estropipate—osteoporosis	0.00137	0.00283	CcSEcCtD
Fidaxomicin—Dermatitis—Estropipate—osteoporosis	0.00137	0.00283	CcSEcCtD
Fidaxomicin—Headache—Estropipate—osteoporosis	0.00136	0.00281	CcSEcCtD
Fidaxomicin—Vomiting—Alendronate—osteoporosis	0.00136	0.00281	CcSEcCtD
Fidaxomicin—Abdominal pain—Risedronate—osteoporosis	0.00136	0.00281	CcSEcCtD
Fidaxomicin—Rash—Alendronate—osteoporosis	0.00135	0.00279	CcSEcCtD
Fidaxomicin—Dermatitis—Alendronate—osteoporosis	0.00135	0.00279	CcSEcCtD
Fidaxomicin—Headache—Alendronate—osteoporosis	0.00134	0.00277	CcSEcCtD
Fidaxomicin—Vomiting—Raloxifene—osteoporosis	0.00134	0.00277	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Pamidronate—osteoporosis	0.00133	0.00276	CcSEcCtD
Fidaxomicin—Dyspnoea—Zoledronate—osteoporosis	0.00133	0.00275	CcSEcCtD
Fidaxomicin—Rash—Raloxifene—osteoporosis	0.00133	0.00274	CcSEcCtD
Fidaxomicin—Dermatitis—Raloxifene—osteoporosis	0.00132	0.00274	CcSEcCtD
Fidaxomicin—Vomiting—Ibandronate—osteoporosis	0.00132	0.00274	CcSEcCtD
Fidaxomicin—Headache—Raloxifene—osteoporosis	0.00132	0.00273	CcSEcCtD
Fidaxomicin—Rash—Ibandronate—osteoporosis	0.00131	0.00272	CcSEcCtD
Fidaxomicin—Dermatitis—Ibandronate—osteoporosis	0.00131	0.00271	CcSEcCtD
Fidaxomicin—Dyspepsia—Zoledronate—osteoporosis	0.00131	0.00271	CcSEcCtD
Fidaxomicin—Headache—Ibandronate—osteoporosis	0.0013	0.0027	CcSEcCtD
Fidaxomicin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.0013	0.00268	CcSEcCtD
Fidaxomicin—Vomiting—Calcitriol—osteoporosis	0.0013	0.00268	CcSEcCtD
Fidaxomicin—Decreased appetite—Zoledronate—osteoporosis	0.00129	0.00268	CcSEcCtD
Fidaxomicin—Nausea—Estropipate—osteoporosis	0.00129	0.00267	CcSEcCtD
Fidaxomicin—Abdominal pain—Pamidronate—osteoporosis	0.00129	0.00267	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00129	0.00266	CcSEcCtD
Fidaxomicin—Angioedema—Estradiol—osteoporosis	0.00129	0.00266	CcSEcCtD
Fidaxomicin—Rash—Calcitriol—osteoporosis	0.00128	0.00266	CcSEcCtD
Fidaxomicin—Dermatitis—Calcitriol—osteoporosis	0.00128	0.00266	CcSEcCtD
Fidaxomicin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00128	0.00265	CcSEcCtD
Fidaxomicin—Headache—Calcitriol—osteoporosis	0.00128	0.00264	CcSEcCtD
Fidaxomicin—Constipation—Zoledronate—osteoporosis	0.00127	0.00264	CcSEcCtD
Fidaxomicin—Nausea—Alendronate—osteoporosis	0.00127	0.00263	CcSEcCtD
Fidaxomicin—Hypersensitivity—Risedronate—osteoporosis	0.00126	0.00262	CcSEcCtD
Fidaxomicin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00126	0.00261	CcSEcCtD
Fidaxomicin—Nausea—Raloxifene—osteoporosis	0.00125	0.00258	CcSEcCtD
Fidaxomicin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00125	0.00258	CcSEcCtD
Fidaxomicin—Pruritus—Ethinyl Estradiol—osteoporosis	0.00124	0.00258	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00124	0.00256	CcSEcCtD
Fidaxomicin—Nausea—Ibandronate—osteoporosis	0.00124	0.00256	CcSEcCtD
Fidaxomicin—Constipation—Conjugated Estrogens—osteoporosis	0.00123	0.00254	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Zoledronate—osteoporosis	0.00122	0.00252	CcSEcCtD
Fidaxomicin—Pruritus—Risedronate—osteoporosis	0.00121	0.00251	CcSEcCtD
Fidaxomicin—Nausea—Calcitriol—osteoporosis	0.00121	0.0025	CcSEcCtD
Fidaxomicin—Hypersensitivity—Pamidronate—osteoporosis	0.0012	0.00249	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00119	0.00246	CcSEcCtD
Fidaxomicin—Abdominal pain—Zoledronate—osteoporosis	0.00118	0.00244	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00117	0.00243	CcSEcCtD
Fidaxomicin—Dry mouth—Estradiol—osteoporosis	0.00117	0.00242	CcSEcCtD
Fidaxomicin—Dizziness—Ethinyl Estradiol—osteoporosis	0.00116	0.00241	CcSEcCtD
Fidaxomicin—Pruritus—Pamidronate—osteoporosis	0.00115	0.00239	CcSEcCtD
Fidaxomicin—Dizziness—Risedronate—osteoporosis	0.00113	0.00235	CcSEcCtD
Fidaxomicin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00113	0.00235	CcSEcCtD
Fidaxomicin—Nervous system disorder—Estradiol—osteoporosis	0.00113	0.00233	CcSEcCtD
Fidaxomicin—Vomiting—Ethinyl Estradiol—osteoporosis	0.00112	0.00231	CcSEcCtD
Fidaxomicin—Skin disorder—Estradiol—osteoporosis	0.00112	0.00231	CcSEcCtD
Fidaxomicin—Rash—Ethinyl Estradiol—osteoporosis	0.00111	0.0023	CcSEcCtD
Fidaxomicin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00111	0.00229	CcSEcCtD
Fidaxomicin—Headache—Ethinyl Estradiol—osteoporosis	0.0011	0.00228	CcSEcCtD
Fidaxomicin—Hypersensitivity—Zoledronate—osteoporosis	0.0011	0.00227	CcSEcCtD
Fidaxomicin—Vomiting—Risedronate—osteoporosis	0.00109	0.00226	CcSEcCtD
Fidaxomicin—Rash—Risedronate—osteoporosis	0.00108	0.00224	CcSEcCtD
Fidaxomicin—Dermatitis—Risedronate—osteoporosis	0.00108	0.00224	CcSEcCtD
Fidaxomicin—Dizziness—Pamidronate—osteoporosis	0.00108	0.00223	CcSEcCtD
Fidaxomicin—Headache—Risedronate—osteoporosis	0.00107	0.00222	CcSEcCtD
Fidaxomicin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00106	0.00219	CcSEcCtD
Fidaxomicin—Pruritus—Zoledronate—osteoporosis	0.00105	0.00218	CcSEcCtD
Fidaxomicin—Nausea—Ethinyl Estradiol—osteoporosis	0.00105	0.00216	CcSEcCtD
Fidaxomicin—Vomiting—Pamidronate—osteoporosis	0.00104	0.00215	CcSEcCtD
Fidaxomicin—Rash—Pamidronate—osteoporosis	0.00103	0.00213	CcSEcCtD
Fidaxomicin—Dermatitis—Pamidronate—osteoporosis	0.00103	0.00213	CcSEcCtD
Fidaxomicin—Dyspnoea—Estradiol—osteoporosis	0.00102	0.00212	CcSEcCtD
Fidaxomicin—Headache—Pamidronate—osteoporosis	0.00102	0.00211	CcSEcCtD
Fidaxomicin—Nausea—Risedronate—osteoporosis	0.00102	0.00211	CcSEcCtD
Fidaxomicin—Pruritus—Conjugated Estrogens—osteoporosis	0.00101	0.0021	CcSEcCtD
Fidaxomicin—Dyspepsia—Estradiol—osteoporosis	0.00101	0.00209	CcSEcCtD
Fidaxomicin—Decreased appetite—Estradiol—osteoporosis	0.000998	0.00206	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000991	0.00205	CcSEcCtD
Fidaxomicin—Dizziness—Zoledronate—osteoporosis	0.000985	0.00204	CcSEcCtD
Fidaxomicin—Constipation—Estradiol—osteoporosis	0.000982	0.00203	CcSEcCtD
Fidaxomicin—Nausea—Pamidronate—osteoporosis	0.000969	0.002	CcSEcCtD
Fidaxomicin—Dizziness—Conjugated Estrogens—osteoporosis	0.000948	0.00196	CcSEcCtD
Fidaxomicin—Vomiting—Zoledronate—osteoporosis	0.000947	0.00196	CcSEcCtD
Fidaxomicin—Rash—Zoledronate—osteoporosis	0.000939	0.00194	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Estradiol—osteoporosis	0.000939	0.00194	CcSEcCtD
Fidaxomicin—Dermatitis—Zoledronate—osteoporosis	0.000938	0.00194	CcSEcCtD
Fidaxomicin—Headache—Zoledronate—osteoporosis	0.000933	0.00193	CcSEcCtD
Fidaxomicin—Vomiting—Conjugated Estrogens—osteoporosis	0.000912	0.00189	CcSEcCtD
Fidaxomicin—Abdominal pain—Estradiol—osteoporosis	0.000907	0.00188	CcSEcCtD
Fidaxomicin—Rash—Conjugated Estrogens—osteoporosis	0.000904	0.00187	CcSEcCtD
Fidaxomicin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000904	0.00187	CcSEcCtD
Fidaxomicin—Headache—Conjugated Estrogens—osteoporosis	0.000899	0.00186	CcSEcCtD
Fidaxomicin—Nausea—Zoledronate—osteoporosis	0.000885	0.00183	CcSEcCtD
Fidaxomicin—Nausea—Conjugated Estrogens—osteoporosis	0.000852	0.00176	CcSEcCtD
Fidaxomicin—Hypersensitivity—Estradiol—osteoporosis	0.000846	0.00175	CcSEcCtD
Fidaxomicin—Pruritus—Estradiol—osteoporosis	0.000812	0.00168	CcSEcCtD
Fidaxomicin—Dizziness—Estradiol—osteoporosis	0.000759	0.00157	CcSEcCtD
Fidaxomicin—Vomiting—Estradiol—osteoporosis	0.00073	0.00151	CcSEcCtD
Fidaxomicin—Rash—Estradiol—osteoporosis	0.000724	0.0015	CcSEcCtD
Fidaxomicin—Dermatitis—Estradiol—osteoporosis	0.000723	0.0015	CcSEcCtD
Fidaxomicin—Headache—Estradiol—osteoporosis	0.000719	0.00149	CcSEcCtD
Fidaxomicin—Nausea—Estradiol—osteoporosis	0.000682	0.00141	CcSEcCtD
